Amalgamated Bank Sells 9,422 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Amalgamated Bank decreased its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 16.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,914 shares of the business services provider’s stock after selling 9,422 shares during the period. Amalgamated Bank owned about 0.05% of Stericycle worth $2,727,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Capital Research Global Investors raised its position in Stericycle by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock valued at $296,762,000 after purchasing an additional 705,586 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of Stericycle by 5.2% in the first quarter. First Eagle Investment Management LLC now owns 242,975 shares of the business services provider’s stock valued at $12,817,000 after buying an additional 12,000 shares during the last quarter. Illinois Municipal Retirement Fund acquired a new position in Stericycle during the 1st quarter worth about $756,000. Sei Investments Co. grew its holdings in Stericycle by 5.9% during the 1st quarter. Sei Investments Co. now owns 1,124,481 shares of the business services provider’s stock worth $59,316,000 after acquiring an additional 63,112 shares during the last quarter. Finally, Quantbot Technologies LP bought a new stake in Stericycle during the 1st quarter worth about $1,023,000. Institutional investors own 98.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on SRCL shares. Royal Bank of Canada reiterated a “sector perform” rating and set a $62.00 target price (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. StockNews.com started coverage on Stericycle in a research report on Tuesday, September 17th. They issued a “hold” rating on the stock. Truist Financial lifted their target price on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods upped their price target on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Stericycle has a consensus rating of “Hold” and an average price target of $74.00.

Stericycle Price Performance

NASDAQ:SRCL opened at $61.68 on Tuesday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $61.77. The stock’s fifty day simple moving average is $59.40 and its 200-day simple moving average is $54.92. The firm has a market capitalization of $5.73 billion, a P/E ratio of -280.36, a P/E/G ratio of 3.37 and a beta of 1.11.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. Equities research analysts expect that Stericycle, Inc. will post 2.29 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.